Back to results
US 2008/0306262 A1Published application
Novel Compound
AssigneeAstraZeneca AB, a Swedish corporation
InventorRoger Victor Bonnert
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.
Claims2
A monosodium salt of the compound of formula (I):
Dependencies are inferred from the claim text.